Big Pharma: Trick or Treat for Global Health

Pavel A. Nalimov, Dmitry Y. Rudenko, Djamilia F. Skripnuk

Abstract


Against the background of certain progress in global health, pharmaceutical industry is becoming a vital mechanism of effective medicines production. At the same time, being a socially-oriented unit of the world economy, the pharmaceutical market at this moment is characterized by particularly high degree of commercialization. Taking this fact into account, the authors aim to search for sufficient answers to the key question - whether pharmaceutical market solves global health problems or exists for the sake of pharmaceutical companies’ profits maximizing. According to the results both the fact of uneven distribution of drugs in the context of developed and developing countries and its causes were established. It is supposed that the economical policy of largest pharmaceutical manufacturers is deliberately based on keeping shipments of innovative drugs in developing countries in static regime. The main conclusion of the pharmaceutical market ineffectiveness at the present stage was obtained by a preliminary analysis of data array using IBM SPSS Statistics 19.

DOI: 10.5901/mjss.2015.v6n1p216


Full Text: PDF

Licenza Creative Commons
This work is licensed under Creative Commons Attribution 3.0 License.

Mediterranean Journal of Social Sciences ISSN 2039-9340(Print) ISSN 2039-2117(Online)

Copyright © MCSER-Mediterranean Center of Social and Educational Research

To make sure that you can receive messages from us, please add the 'mcser.org' domain to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', check your 'bulk mail' or 'junk mail' folders..